ClarusC64/clinical-quad-biomarker-subpopulation-dosing-endpoint-drift-v0.1 Viewer • Updated 3 days ago • 10 • 97
ClarusC64/clinical-quad-immunogenicity-dosing-interval-antibody-efficacy-decay-v0.1 Viewer • Updated 3 days ago • 10 • 41
